Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Sep 26;396(10255):868-869.
doi: 10.1016/S0140-6736(20)31867-5. Epub 2020 Sep 4.

COVID-19 vaccines: early success and remaining challenges

Naor Bar-Zeev  1 , Tom Inglesby  2
Affiliations
Comment

COVID-19 vaccines: early success and remaining challenges

Naor Bar-Zeev et al. Lancet. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Logunov DY, Dolzhikova IV, Zubkova OV. Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open-label, non-randomised phase 1/2 studies from Russia. Lancet. 2020 doi: 10.1016/S0140-6736(20)31866-3. published online Sept 4. - DOI - PMC - PubMed
    1. Zhu F-C, Guan X-H, Li Y-H. Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet. 2020;396:479–488. - PMC - PubMed
    1. Folegatti PM, Ewer KJ, Aley PK. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. Lancet. 2020;396:467–478. - PMC - PubMed
    1. Jackson LA, Anderson EJ, Rouphael NG. An mRNA vaccine against SARS-CoV-2: preliminary report. N Engl J Med. 2020 doi: 10.1056/NEJMoa2022483. published online July 14. - DOI - PMC - PubMed
    1. Lambert P-H, Ambrosino DM, Andersen SR. Consensus summary report for CEPI/BC March 12–13, 2020 meeting: assessment of risk of disease enhancement with COVID-19 vaccines. Vaccine. 2020;38:4783–4791. - PMC - PubMed